CTRI/2018/03/012755尚未招募未知
Expression of Ki-67 in multiple myeloma - a clinicopathological study
Dharamshila Hospital and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •50 cases Multiple Myeloma diagnosed at our hospital will be examined and studied.
排除标准
- •The following cases are excluded-
- •1)Post Chemotherapy (CT) patients
- •2)Post Radiotherapy (RT) patients
- •3)Plasmacytoma cases
- •4)Plasma cell leukemia cases
研究者
相似试验
尚未招募
不适用
the association between Ki67 and clinical features in patients with advanced EGFR-positive lung adenocarcinoma40 cases diagnosed advanced lung adenocarcinoma. The 20 cases were EGFR mutation positive and treated with EGFR inhibitors, and the other 20 cases are EGFR mutation negative and treated with chemotherapy and/or immunotherapy.JPRN-UMIN000042886Tohoku Medical and Pharmaceutical University,Tohoku Medical and Pharmaceutical University Hospital40
已完成
不适用
Identification and Semi-Quantification of Ki-67 Protein Expression StatusBreast CancerNCT02654457Applied Spectral Imaging Ltd.3
已完成
不适用
Myeloma VII - myelomatosis therapy trialeukaemiaCancerLeukaemiaISRCTN66518389Medical Research Council (MRC) (UK)750
尚未招募
不适用
Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?Myelodysplastic SyndromesMyelodysplastic Syndrome/NeoplasmAcute Myeloid LeukemiaNCT04517175Maastricht University300
招募中
不适用
Clinical Myeloma Registry GMMGC.90.0DRKS00026970niversitätsklinikum Heidelberg999